Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial experience with a practical hyperfractionated accelerated radiotherapy regimen.

A Herskovic1, C Orton, M Seyedsadr

  • 1Radiation Oncology Department, Wayne State University, Detroit, MI.

International Journal of Radiation Oncology, Biology, Physics
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease.

ESMO open·2026
Same author

VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival.

medRxiv : the preprint server for health sciences·2025
Same author

The 'Wirral Wedge': an aid to position arm safely in upper limb surgery.

Annals of the Royal College of Surgeons of England·2024
Same author

Rain triggers seasonal stratification in a temperate shelf sea.

Nature communications·2023
Same author

Charges and Specifications: Preferred against Brigadier-General William A. Hammond, Surgeon-General United States Army.

Buffalo medical and surgical journal·2023
Same author

The Secure Anonymised Information Linkage databank Dementia e-cohort (SAIL-DeC).

International journal of population data science·2020

This study introduces a convenient radiotherapy schedule, delivering three fractions daily (TID), which shows improved tumor control and reduced toxicity compared to historical data. This accelerated fractionation enhances treatment effectiveness and patient outcomes.

Area of Science:

  • Radiation Oncology
  • Clinical Trials

Background:

  • Continuous Hyperfractionated Accelerated Radiotherapy (CHART) is a complex European protocol.
  • A modified TID regimen offers improved scheduling convenience.

Purpose of the Study:

  • To evaluate the efficacy and toxicity of a modified TID radiotherapy regimen.
  • To compare outcomes with historical controls and predict tumoricidal effectiveness.

Main Methods:

  • Modified CHART regimen: 72 fractions of 1.1 Gy TID over 24 treatment days (less than 5 weeks).
  • Dose determination using the Linear-Quadratic (L-Q) model with corrections for incomplete repair and accelerated repopulation.
  • Comparison with historical control data.

Main Results:

Related Experiment Videos

  • Statistically significant improvements in Complete Response (CR) rates for the primary tumor.
  • Significant reduction in acute toxicity, evidenced by fewer treatment interruptions.
  • L-Q model predicts a 12% increase in bioeffect dose to the primary tumor.
  • Potential for a one log cell kill advantage over other accelerated fractionation schedules for short Tpot.

    • Conclusions:

    • The modified TID regimen demonstrates superior efficacy and safety compared to historical controls.
    • Accelerated treatment schedules, like this TID regimen, can enhance tumoricidal effectiveness.
    • This approach offers a promising alternative for radiotherapy, improving local control potential.